PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Consolidated Net Profit | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹376 Cr |
Mar2021 | ₹835 Cr |
How is Consolidated Net Profit of PIRAMAL PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | Positive | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹376 Cr | -54.98 | |
Mar2021 | ₹835 Cr | - |
Compare Consolidated Net Profit of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹25,926.0 Cr | -2% | -5.5% | 23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -2% |
-5.5% |
23.2% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses